XML 15 R6.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 9 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Cash Flows from Operating Activities    
Net loss before accrued preferred dividends and noncontrolling interest $ (806,795,641) $ (485,517,181)
Adjustments to reconcile net loss attributable to shareholders to net cash used in operating activities:    
Depreciation and amortization 10,991,239 918,855
Stock-based compensation 71,015,371 32,479,710
Issuance of warrants to suppliers 6,814,000  
Non-cash financing loss on over-exercise of warrants 8,934,892  
Revaluation of derivative liabilities 89,462,559 124,868,232
Initial recognition of derivative liabilities 504,373,115 269,344,178
Non-cash interest and other operating activities (1,656,288) 3,879,496
Amortization of debt discount 442,091 19,584,041
Loss on asset disposal   50,574
Loss/(gain) on extinguishment of debt 6,246,089 (33,413)
Changes in operating assets and liabilities:    
Other current assets (15,319,813) 5,446,031
Other assets 1,230,337 (1,960,058)
Accounts payable 6,013,276 (2,129,901)
Accrued expenses and other liabilities 4,835,588 (10,119,169)
Deferred tax liability (445,808)  
Right of use assets and lease liabilities 231,048 (31,989)
Net cash used in operating activities (113,627,945) (43,220,594)
Cash Flows from Investing Activities    
Purchase of equipment (14,328,228) (10,968,389)
Purchase of intangible assets (204,660) (305,043)
ELMS assets purchase (92,916,874)  
Net cash used in investing activities (107,449,762) (11,273,432)
Cash Flows from Financing Activities    
Proceeds from issuance of notes payable 170,000,000 12,142,791
Proceeds from issuance of common stock and prefunded warrants 196,999,970 40,151,308
Proceeds from issuance of preferred stock   63,925,000
Reimbursement for over-issuance of shares 17,819,660  
Proceeds from note receivable   15,000,000
Payment of notes payable (20,685,000) (15,655,983)
Net cash provided by financing activities 364,134,630 115,563,116
Increase in cash 143,056,923 61,069,090
Cash, cash equivalents and restricted cash, beginning of period 84,375,085 42,174
Cash, cash equivalents and restricted cash, ending of period 227,432,008 61,111,264
Supplemental disclosure of Cash Flow information:    
Cash paid for interest 122,500 1,500,106
Supplemental Disclosure for Non-Cash Activities:    
Refinance of indebtedness   28,867,187
Preferred shares issued in exchange for convertible debt   23,192,500
Convertible notes and interest - conversion to common stock 153,222,236 17,356,500
Exercise of warrants recognized earlier as liabilities 391,057,576 $ 420,626,121
Reclassification of derivatives to equity upon authorization of sufficient number of shares 47,818,882  
Waiver of dividends by stockholders 7,387,810  
Warrants issued to suppliers 6,814,000  
Common stock issued to extinguish liability to issue stock 66,752,533  
Extinguishment of financial liabilities by sale of property 231,958  
Extinguishment of operational liabilities by sale of property 767,626  
Debt conversion to common stock 1,096,787  
Prepaid stock-based compensation 3,909,404  
Preferred stock converted to common stock 273,364  
Prefunded warrants converted to common stock $ 250,466